drugset / Trial / NCT02338336
A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate drug safety and efficacy in patients treated with Nowarta110 and to determine therapeutic activity against Plantar Warts * Clinical Tolerance * Clinical Recovery * Evaluate Safety
Timeline
- Start
- 2015-02
- Primary completion
- 2015-09
- Completion
- 2015-12
Outcome
Met primary endpoint
registry analysis (superiority or other test); Placebo vs TREATMENT; p <0.001; ANOVA NCT02338336 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fig extract | Unknown | 3 unknown | Topical |
| Subject | fig extract | Unknown | 6 unknown | Topical |
| Subject | fig extract | Unknown | 10 unknown | Topical |